Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department
NCT ID: NCT00766181
Last Updated: 2010-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
200 participants
OBSERVATIONAL
2008-10-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department
NCT00681902
A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children
NCT03653260
J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion
NCT00924963
A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization
NCT01690767
A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures
NCT00142064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1: Lifestyle
Observatonal
No interventions assigned to this group
2: Lifestyle
Observational
Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system
0.5 mg lidocaine hydrochloride
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system
0.5 mg lidocaine hydrochloride
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parent must be able to read and understand English and provide written informed consent
* Parent must be present during the IV placement
* PHASE B: Parent did not participate in Phase A
* Nurse has completed Zingo TM in-service training prior to participation
* Zingo is used prior to performing the IV placement procedure
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Covance
INDUSTRY
Anesiva, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anesiva, Inc.
Related Links
Access external resources that provide additional context or updates about the study.
Anesiva home page
Zingo Product Information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
113-03P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.